Effect of Colchicine on Tumor Markers in Patients with Gouty Arthritis / 医学研究杂志

ABSTRACT

Objective To explore the influence of different doses and courses of colchicine on tumor markers in patients with gouty arthritis.Methods Totally 102 patients with acute gouty arthritis were divided into group 1 (had taken colchicine before in hospital)and group 2 (hadn't taken colchicine before in hospital).Group 2 was divided into two subgroups,group 2A and group 2B.We also included 31 cases of non-gouty arthritis patients in the same period in the hospital as control group.Group 2A and group 1 were given 0.5 mg bid of colchicine and corresponding NSAID on the day admitted to hospital.Group 2B were given the same dose of colchicine the next day.Blood sedimentation,c-reactive protein,serum creatinine,blood uric acid,CA724,AFP,CEA,CA125,CA153 and CA199 were detected in all patients on the next day admitted to hospital.Then we analyzed the differences and influencing factors among the groups.Retest CA724 1 week later,and follow-up parts of patients,reevaluate CA724 again after stopping using colchicine.Results Compared with the control group,CA724 significantly elevated in patients who took colchicine,and the difference was statistically significant.CA724 level of day 1 in group 2A was obviously higher than that of group 2B,and the difference between the two groups was statistically significant.It showed that very low dose colchicine can also result in higher CA724,and the level was closely relative to total dose and using course.After stopping drug,CA724 value can drop to normal range.Conclusion Colchicine can significantly affect the level of serum CA724,which gradually rise with the increase of drug dose and course.It can be back to normal after drug withdrawal.The discovery can avoid the clinical misdiagnosis and excessive medical treatment,It has certain guiding significance.